Cover Image
市場調查報告書

神經修復、再生的全球市場的預測 ∼2022年:各治療方法(神經縫合術、神經移植術、幹細胞治療、神經刺激術)、產品(生物材料、神經管、神經保護器、神經包裝紙、神經刺激設備)、地區

Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 281743
出版日期 內容資訊 英文 124 Pages
訂單完成後即時交付
價格
Back to Top
神經修復、再生的全球市場的預測 ∼2022年:各治療方法(神經縫合術、神經移植術、幹細胞治療、神經刺激術)、產品(生物材料、神經管、神經保護器、神經包裝紙、神經刺激設備)、地區 Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022
出版日期: 2017年11月10日 內容資訊: 英文 124 Pages
簡介

全球神經修復、再生市場規模,預計從2017到2022年以12.9%的年複合成長率(CAGR)發展,2017年達57億9000萬美元,到2022年擴大為105億9000萬美元規模。神經損傷案例的增加,及高齡化的進展伴隨的神經疾病的增加等成為這個市場主要促進因素。

本報告提供全球神經修復、再生市場相關調查,市場概要,各治療方法、產品、地區的市場趨勢,市場規模的變化與預測,市場成長的各種影響要素分析,競爭環境,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 神經修復、再生市場概要
  • 亞洲的神經修復、再生市場:各用途、各國
  • 神經修復、再生市場:各地區的概要
  • 神經移植市場:各類型

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
      • 神經損傷案例的增加
      • 高齡化的進展伴隨的神經疾病的增加
      • 技術的進步
    • 阻礙因素
      • 比神經修復、重組療法更首選的醫藥品的治療
      • 專家的不足
    • 市場機會
      • 新興市場
      • 神經修復、再生術的幹細胞治療的潛在性
    • 課題
      • 生物捐贈者的併發症
      • 嚴格法規與到核准為止的漫長路程

第6章 神經修復、再生的全球市場:各產品

  • 簡介
  • 神經刺激、神經調整設備
    • 內部神經刺激設備
      • 脊髓刺激
      • 深部腦刺激
      • 迷走神經刺激
      • 薦椎神經刺激
      • 胃電刺激
    • 外部神經刺激設備
      • 經皮電力神經刺激
      • 經顱磁刺激
  • 生物材料
    • 神經管
    • 神經保護器
    • 神經包裝紙
    • 神經連接器

第7章 神經修復、再生的全球市場:各治療法

  • 簡介
  • 神經刺激、神經調節手術
    • 內部
    • 外部
  • 直接神經修復、神經縫合術
    • 神經上膜修復
    • 神經周圍修復
    • 群組神經束脩復
  • 神經移植術
    • 自體移植
    • 同類移植
    • 異種移植
  • 幹細胞治療

第8章 神經修復、再生的全球市場:各終端用戶

  • 簡介
  • 醫院、診療所
  • 門診外科中心

第9章 神經修復、再生的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 其他

第10章 競爭環境

  • 簡介
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 法規、核准
    • 合併、收購
    • 新產品的發表
    • 協定、聯盟、合作

第11章 企業簡介

  • AXOGEN
  • BAXTER
  • BOSTON SCIENTIFIC
  • LIVANOVA
  • INTEGRA LIFESCIENCES
  • MEDTRONIC
  • ABBOTT LABORATORIES
  • STRYKER
  • POLYGANICS
  • NUVECTRA
  • NEUROPACE
  • ORTHOMED
  • NEVRO

第12章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 3642

The nerve repair and regeneration market is expected to reach USD 10.59 million by 2022 from USD 5.79 billion in 2017, at a CAGR of 12.9%. Factors such as increasing number of neurological disorders, technological advancements, and rising geriatric population are driving the growth of this market. On the other hand, donor-site morbidity, difficulties in treating large nerve gaps, and stringent regulatory frameworks and time-consuming approval processes may challenge the growth of the market.

Neurostimulation and neuromodulation devices segment is expected to account for the largest share in the market

On the basis of product, the nerve repair and regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. In 2017, the neurostimulation and neuromodulation devices segment is expected to account for the largest share of this market segment. This growth can be attributed to the increasing neurological disorders and favorable reimbursement policies.

Internal neurostimulation and neuromodulation surgeries segment is expected to register the highest CAGR during the forecast period

Based on application, the nerve repair and regeneration market is segmented into into internal neurostimulation and neuromodulation surgeries and external neurostimulation and neuromodulation surgeries. The internal neurostimulation and neuromodulation surgeries segment is expected to register highest growth rate during the forecast period. This growth can be attributed to its wide application in neurological disorders.

North America is expected to account for the largest regional segment in the market

Geographically, the nerve repair and regeneration market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region and growing incidence of peripheral nerve injuries.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 35%, Tier 2 - 22% and Tier 3 - 43%
  • By Designation - C level - 15%, Director level - 32%, Others - 53%
  • By Region - North America - 32%, Europe - 27%, Asia - 22%, RoW - 19%

Key players operating in the nerve repair and regeneration market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), LivaNova (UK), Baxter (US), AxoGen (US), and Stryker (US).

Study Coverage:

The report analyses the nerve repair and regeneration market by product, applications, end user, and regions. Apart from comprehensive geographic and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

  • Market Penetration: The report analyzes the nerve repair and regeneration market by product, application, and end user
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the nerve repair and regeneration market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various nerve repair and regeneration product across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the nerve repair and regeneration market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. NERVE REPAIR AND REGENERATION: MARKET OVERVIEW
  • 4.2. ASIAN NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION AND COUNTRY
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE NERVE REPAIR AND REGENERATION MARKET
  • 4.4. NERVE GRAFTING MARKET, BY TYPE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High incidence of nerve injuries
      • 5.2.1.2. Rising geriatric population and subsequent growth in the prevalence of neurological disorders
      • 5.2.1.3. Technological advancements
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Greater preference for drug therapies over nerve repair and regeneration products
      • 5.2.2.2. Dearth of trained professionals
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Potential of stem cell therapy in nerve repair and regeneration
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Donor-site morbidity
      • 5.2.4.2. Difficulties in treating large nerve gaps
      • 5.2.4.3. Stringent regulatory frameworks and time-consuming approval processes

6. NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. NEUROSTIMULATION AND NEUROMODULATION DEVICES
    • 6.2.1. INTERNAL NEUROSTIMULATION DEVICES
      • 6.2.1.1. Spinal cord stimulation
      • 6.2.1.2. Deep brain stimulation
      • 6.2.1.3. Vagus nerve stimulation
      • 6.2.1.4. Sacral nerve stimulation
      • 6.2.1.5. Gastric electrical stimulation
    • 6.2.2. EXTERNAL NEUROSTIMULATION DEVICES
      • 6.2.2.1. Transcutaneous electrical nerve stimulation
      • 6.2.2.2. Transcranial magnetic stimulation
  • 6.3. BIOMATERIALS
    • 6.3.1. NERVE CONDUITS
    • 6.3.2. NERVE PROTECTORS
    • 6.3.3. NERVE WRAPS
    • 6.3.4. NERVE CONNECTORS

7. NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. NEUROSTIMULATION AND NEUROMODULATION SURGERIES
    • 7.2.1. INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES
    • 7.2.2. EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES
  • 7.3. DIRECT NERVE REPAIR/NEURORRHAPHY
    • 7.3.1. EPINEURAL REPAIR
    • 7.3.2. PERINEURAL REPAIR
    • 7.3.3. GROUP FASCICULAR REPAIR
  • 7.4. NERVE GRAFTING
    • 7.4.1. AUTOGRAFTS
    • 7.4.2. ALLOGRAFTS
    • 7.4.3. XENOGRAFTS
  • 7.5. STEM CELL THERAPY

8. NERVE REPAIR AND REGENERATION MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS & CLINICS
  • 8.3. AMBULATORY SURGERY CENTERS

9. NERVE REPAIR AND REGENERATION MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. REGULATORY APPROVALS
    • 10.3.2. MERGERS AND ACQUISITIONS
    • 10.3.3. PRODUCT LAUNCHES
    • 10.3.4. AGREEMENTS, COLLABORATION AND PARTNERSHIPS

11. COMPANY PROFILES (Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*

  • 11.1. AXOGEN
  • 11.2. BAXTER
  • 11.3. BOSTON SCIENTIFIC
  • 11.4. LIVANOVA
  • 11.5. INTEGRA LIFESCIENCES
  • 11.6. MEDTRONIC
  • 11.7. ABBOTT LABORATORIES
  • 11.8. STRYKER
  • 11.9. POLYGANICS
  • 11.10. NUVECTRA
  • 11.11. NEUROPACE
  • 11.12. ORTHOMED
  • 11.13. NEVRO

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 2: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: VAGUS NERVE STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: SACRAL NERVE STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: GASTRIC ELECTRICAL STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 12: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: TENS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: TMS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 16: BIOMATERIALS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NERVE CONDUITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NERVE PROTECTORS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: NERVE WRAPS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NERVE CONNECTORS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 22: NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 23: NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 27: DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: EPINEURAL REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: PERINEURAL REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: GROUP FASCICULAR REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NERVE GRAFTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 32: NERVE GRAFTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: AUTOGRAFTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: ALLOGRAFTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: XENOGRAFT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: STEM CELL THERAPY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: NERVE REPAIR AND REGENERATION MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 38: NERVE REPAIR AND REGENERATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: NERVE REPAIR AND REGENERATION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: US: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 50: NEUROLOGICAL CONDITIONS IN CANADA
  • TABLE 51: CANADA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: NORTH AMERICA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 59: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: ASIA: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 67: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 68: CHINA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 69: JAPAN: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: INDIA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 71: ROA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 72: ROW: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 73: ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: ROW: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: ROW: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: ROW: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: ROW: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 78: ROW: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 79: GROWTH STRATEGY MATRIX, 2014-2017
  • TABLE 80: REGULATORY APPROVAL, 2014-2017
  • TABLE 81: MERGERS AND ACQUISITIONS, 2014-2017
  • TABLE 82: PRODUCT LAUNCHES, 2014-2017
  • TABLE 83: AGREEMENTS, COLLABORATION, AND PARTNERSHIPS, 2014-2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: NERVE REPAIR & REGENERATION MARKET
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: NERVE REPAIR AND REGENERATION MARKET SIZE, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: HIGH INCIDENCE OF NERVE INJURIES AND GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE THE MARKET GROWTH
  • FIGURE 11: NEUROSTIMULATION AND NEUROMODULATION SURGERIES TO DOMINATE THE ASIAN NERVE REPAIR AND REGENERATION MARKET IN 2017
  • FIGURE 12: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 13: XENOGRAFTS WILL CONTINUE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 14: NERVE REPAIR AND REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: NEUROSTIMULATION AND NEUROMODULATION DEVICES, THE LARGEST PRODUCT SEGMENT IN THE MARKET
  • FIGURE 16: NEUROSTIMULATION AND NEUROMODULATION SURGERIES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: HOSPITALS & CLINICS SEGMENT TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET IN 2017
  • FIGURE 19: ASIA TO REGISTER THE HIGHEST CAGR IN THE NERVE REPAIR AND REGENERATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT
  • FIGURE 21: ASIA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT
  • FIGURE 22: NERVE REPAIR AND REGENERATION MARKET: MARKET SHARE (2016)
  • FIGURE 23: AXOGEN: COMPANY SNAPSHOT (2016)
  • FIGURE 24: BAXTER: COMPANY SNAPSHOT (2016)
  • FIGURE 25: BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 26: LIVANOVA: COMPANY SNAPSHOT (2016)
  • FIGURE 27: INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2016)
  • FIGURE 28: MEDTRONIC: COMPANY SNAPSHOT (2016)
  • FIGURE 29: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 30: STRYKER: COMPANY SNAPSHOT (2016)
  • FIGURE 31: NERVO: COMPANY SNAPSHOT (2016)
Back to Top